The Assisted Reproductive Technology (ART) Market  is poised for significant growth in the coming years, according to a recent report published by [Your Company Name]. The report reveals that the ART market, valued at USD 24.7 billion in 2022, is expected to reach USD 38.48 billion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.70% over the forecast period of 2023-2030.

Assisted Reproductive Technology (ART) encompasses various medical procedures used to achieve pregnancy by manipulating sperm, eggs, or embryos outside the body. ART procedures include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer (GIFT), and others. The growing prevalence of infertility, advancements in reproductive technologies, and changing societal attitudes towards family planning are driving the demand for ART services worldwide.

Get Sample PDF @ 

Key Players

The major key players are Cosmos Biomedical, Microm, CooperSurgical, Fujifilm Irvine Scientific, Cryolab, Vitrolife, European Sperm Bank, Bloom IVF Centre, Merck KGaA, Ferring B.V. and others.

Key highlights from the report include:

  1. Increasing Incidence of Infertility: The prevalence of infertility is on the rise globally, attributed to factors such as lifestyle changes, delayed childbearing, environmental factors, and underlying medical conditions. As couples facing infertility seek alternative reproductive solutions, the demand for ART procedures continues to grow, contributing to market expansion.

  2. Technological Advancements in Reproductive Medicine: Ongoing advancements in reproductive medicine and laboratory techniques are enhancing the success rates of ART procedures. Innovations such as preimplantation genetic testing (PGT), time-lapse embryo imaging, and embryo culture optimization are improving embryo selection and implantation outcomes, thereby driving the adoption of ART services.

  3. Expanding Access to ART Services: Improvements in healthcare infrastructure, increasing awareness about fertility treatments, and favorable government initiatives are expanding access to ART services in both developed and developing countries. Moreover, the growing acceptance of non-traditional family structures and the desire for biological parenthood among LGBTQ+ individuals are fueling the demand for ART procedures.

  4. Aging Population and Delayed Childbearing: The trend towards delayed childbearing, particularly among women in their late 30s and 40s, is contributing to the growing demand for ART services. As women postpone childbearing for career or personal reasons, the likelihood of age-related fertility issues increases, necessitating the use of assisted reproductive technologies to achieve pregnancy.

  5. Regulatory Framework and Ethical Considerations: The ART market is subject to regulatory oversight and ethical considerations related to embryo manipulation, genetic testing, and the use of donor gametes. Regulatory agencies play a crucial role in ensuring the safety, efficacy, and ethical conduct of ART procedures, thereby influencing market dynamics and adoption rates.

Key Market Segmentation

By Type

  • In-Vitro Fertilization

  • Artificial Insemination

By End-Use Outlook

  • Fertility Clinics & Other Facilities

  • Hospitals & Care

As the demand for ART services continues to rise, key market players are focusing on expanding their service offerings, enhancing laboratory capabilities, and investing in research and development to address emerging challenges and meet evolving patient needs.


About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

[email protected]

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: https://www.sns